Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-03
2010-02-23
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S455000
Reexamination Certificate
active
07666898
ABSTRACT:
Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.
REFERENCES:
patent: 5504073 (1996-04-01), Homan
patent: 5654326 (1997-08-01), Bach et al.
patent: 6325991 (2001-12-01), Draheim
patent: 6407102 (2002-06-01), Mahoobi et al.
patent: 6451839 (2002-09-01), Bach et al.
patent: 6608099 (2003-08-01), Mihelich et al.
patent: 6630496 (2003-10-01), Seehra et al.
patent: 6706752 (2004-03-01), Lin et al.
patent: 6730694 (2004-05-01), Beight et al.
patent: 6831095 (2004-12-01), Harper
patent: 2003/0087944 (2003-05-01), Macias et al.
patent: 2004/0077704 (2004-04-01), Beight
patent: 0315349 (1989-10-01), None
patent: 0620214 (1994-10-01), None
patent: 0620215 (1994-10-01), None
patent: 0675110 (1995-10-01), None
patent: 0675110 (1995-10-01), None
patent: WO 98 08818 (1998-03-01), None
patent: WO 99 43672 (1999-09-01), None
patent: WO0007590 (2000-02-01), None
patent: WO 0007591 (2000-02-01), None
patent: WO 0037358 (2000-06-01), None
patent: WO 0105761 (2001-03-01), None
patent: WO 0121587 (2001-03-01), None
patent: WO 01 51003 (2001-07-01), None
patent: WO 02074342 (2002-09-01), None
patent: WO 03 048122 (2003-06-01), None
patent: 2005/107766 (2005-11-01), None
S. Hagishita et al; “Potent Inhibitors of Secretory Phospholipase A2. Synthesis and Inhibitory Activities of Indolizine and Indene Derivatives.” Journal of Medicinal Chemistry; vol. 30, 1996, pp. 3636-3658, XP002395282.
D. ST. C. Black et al.; “Calix[3]indoles, New Macrocyclic Tris (indolylmethylene) Compounds with 2, 7-Linkages.” Journal of the Chemical Society, Chemical Communications, vol. 1993, 1003, pp. 819-822, XP002265922.
J. Bloxham et al.; “Synthesis and Solid State Structures of N,N′-Linked Carbazoles and Indoles” Tetrahedron, vol. 58, 2002, pp. 3709-3720.
Robert D. Dillard et al; Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A-2. 2. Indole-3-acetamides with additional Functionality; Journal of Medicinal Chemistry; vol. 30, No. 26, 1996, pp. 5137-5158; XP002424901.
Susan E. Draheim et al; Indole Inhibitors oh Human Nonpancreatic secretory phospholipase A-2. 3. Indole-3-glyoxamides; Journal of Medicinal Chemistry; vol. 30, No. 26; 1996; pp. 5159-5175; XP002424902.
Scott J. Sawyer et al; Carbocyclic(g)indole Inhibitors of Human Nonpancreatic s-PLA2; Journal of Medicinal Chemistry; vol. 48, No. 3; Feb. 10, 2005; pp. 893-896; XP002424903.
Stokes, et al., Hypercholesterolemia Promotes Inflammation and Microvascular Dysfunction; Role of Nitric Oxide and Superoxide, vol. 33, Issue 8,Oct. 15, 2002, pp. 1026-1036.
Goyal & Shah, Novel Anti-Obesity Drugs in Type II Diabetes, Indian Journal of Pharmacology 2002; 34:372-373.
Richmond, et al., Compensatory Phospholipid Digestion is Required for Cholesterol Absorption in Pancreatic Phospholipase A2-Deficient Mice, Gastroenterology 2001:120:1193-1202.
Yedgar, et al., Control of Inflammatory Processes by Cell-Impermeable Inhibitors of Phospholipase A2, AAS 46, Novel Molecular Approaches to Anti-Inflammatory Theory, 1995 Birkhauser Verlag Basel, pp. 77-84.
Juhl, et al., Secretory Phospholipase A2 is Released From Pancreatic Beta-Cells and Stimulates Insulin Secretion Via Inhibition of ATP-Dependent K+ Channels, Biomedical and Biophysical Research Communications 310 (2003) 274-279.
Tanaka, et al., Enhancement of Insulin Release Due to Inhibition of Phospholipase A2 Activity, Horm. Metabol. Res. 15 (1983) 255-256.
Office Action mailed Dec. 16, 2008 for U.S. Appl. No. 11/593,176.
Response to Office Action Filed Mar. 16, 2009 for U.S. Appl. No. 11/593,176.
Buysse Jerry M.
Cartigny Damien
Chang Han-Ting
Charmot Dominique
Chen Shiah-yun
Anderson Rebecca L
Ilypsa, Inc.
McAndrews Held & Malloy Ltd.
Young Shawquia
LandOfFree
Multivalent indole compounds and use thereof as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multivalent indole compounds and use thereof as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multivalent indole compounds and use thereof as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4197843